Physician Assistant · Rochester, NY
NPI
1184958415
Since 2009
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
222 Alexander St Ste 3000
Rochester, NY, 14607
Phone (585) 922-8350
Groups this clinician bills Medicare through
Medicare paid, 2024
$9,460
165 services
Medicare patients, 2024
118
Average age 68
Drug cost, 2024
$27.5M
13,788 prescriptions
Company payments, 2025
$3,133
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Anne Marie Holly was code 99214 (office e&m - established), 114 times for 91 patients. In total Anne Marie Holly billed 165 services in 7 codes, and Medicare paid $9,460.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-06-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 114 | 91 | $61.80 | $7,045 |
| 99213 Office E&M - Established | Office | 27 | 26 | $44.06 | $1,190 |
By year: 2022 $2,055 for 46 services; 2023 $8,567 for 185 services; 2024 $9,460 for 165 services.
Medicare prescription drug claims, 2024
In 2024, the drug Anne Marie Holly prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 1,840 prescriptions and refills. In total Anne Marie Holly wrote 13,788 Medicare prescriptions that cost $27.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 1,840 | 3,573 | 648 | $69K |
| Methotrexate Methotrexate Sodium | 1,440 | 2,694 | 622 | $41K |
| Humira(Cf) Pen Adalimumab | 902 | 1,083 | 190 | $8.4M |
| Prednisone Generic | 776 | 1,169 | 336 | $4,830 |
| Leflunomide Generic | 472 | 891 | 194 | $25K |
| Enbrel Sureclick Etanercept | 418 | 558 | 110 | $4.0M |
| Sulfasalazine Generic | 346 | 655 | 145 | $10K |
| Celecoxib Generic | 322 | 478 | 117 | $11K |
| Xolair Omalizumab | 239 | 254 | 47 | $718K |
| Montelukast Sodium Generic | 234 | 490 | 82 | $2,715 |
| Dupixent Pen Dupilumab | 227 | 279 | 46 | $983K |
| Gabapentin Generic | 222 | 349 | 70 | $3,633 |
| Sulfasalazine Dr Sulfasalazine | 219 | 378 | 76 | $8,799 |
| Azelastine Hcl Generic | 197 | 364 | 75 | $7,118 |
| Duloxetine Hcl Generic | 192 | 324 | 62 | $5,829 |
Brand drugs: - claims; generic drugs: 8,814 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Anne Marie Holly $3,133 ($3,133 in general payments such as food, travel and fees) from 12 companies. The largest payer was Takeda Pharmaceuticals U.S.A., Inc. with $1,555.
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 1 | $1,555 |
| Amgen Inc. AMGN | 10 | $351 |
| Janssen Biotech, Inc. JNJ | 12 | $347 |
| AstraZeneca Pharmaceuticals LP AZN | 7 | $236 |
| Ionis Pharmaceuticals, Inc. IONS | 5 | $178 |
| Genzyme Corporation SNY | 3 | $176 |
| UCB, Inc. UCB.BR | 4 | $104 |
| GlaxoSmithKline, LLC. GSK | 4 | $90.84 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $41.82 |
| Regeneron Healthcare Solutions, Inc. REGN | 1 | $20.68 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.